V-Square Quantitative Management’s 10x Genomics TXG Stock Holding History

V-Square Quantitative Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$68.5K	Buy	+758	New	+$44.3K	0.01%	564

Other funds holding TXG

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

V-Square Quantitative Management's TXG Position: Q3 2026 in Review

V-Square Quantitative Management opened a new position in 10x Genomics (TXG) in Q3 2026: 758 shares worth $68.5K. The stake represents 0.01% of the portfolio and ranks #564 among its holdings.

59 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

V-Square Quantitative Management held 758 shares of 10x Genomics worth $68.5K as of Q3 2026.
10x Genomics was a new V-Square Quantitative Management position in Q3 2026.
10x Genomics made up 0.01% of V-Square Quantitative Management's portfolio in Q3 2026, its #564 holding.
59 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.